Cape Town – JSE Limited-listed Aspen Pharmacare (APN), South Africa’s largest pharmaceutical company, was presented with the Economic Diplomacy (Africa) Award by the South African Government at the prestigious 4th annual Ubuntu Awards, held in Cape Town on 22 March 2018. Accepting the award from Lindiwe Sisulu, Minister of International Relations and Cooperations (“Dirco”) on…

Aspen Pharmacare billionaire Steven Saad opens up with the inside story of the fall of his shares. Exclusive on CNBC Africa first in business worldwide. CNBC Exclusive with Aspen CEO Stephen Saad from Aspen Pharmacare Pty Limited on Vimeo.

Price gouging is not in Aspen’s DNA, says founder Stephen Saad, incensed at the thought that his company would exploit the sick. But Aspen’s predicament, and that of all drug firms, boils down to the tension between a drug company’s perceived responsibility to provide life-saving drugs to patients at a reasonable price, and its natural…

One of Aspen’s key business imperatives is the creation of stakeholder value. The communities Aspen operates within remain amongst the Group’s most important stakeholders, with healthcare being one of the key aspects to ensuring sustainable communities. While South Africa is currently burdened with one of the world’s most disproportionate disease profiles, it also has enthusiastic…

Durban – JSE Limited-listed Aspen Pharmacare (APN), a leading pharmaceutical company in the southern hemisphere, has welcomed the statement issued by the Democratic Alliance (“DA”) earlier today in which it has confirmed that it is satisfied that there is no evidence that Aspen has engaged in alleged anti-competitive behavior as per the DA’s statement issued…

Windhoek, Namibia – JSE Limited listed Aspen Pharmacare (APN), a leading pharmaceutical company in the southern hemisphere, has announced that a memorandum of understanding (“M.O.U”) has been concluded between Aspen’s Russian business and the Vladivostok Far Eastern Federal University (“F.E.F.U”). The Deputy Prime Minister of Russia Mr. Yury Trutnev, who has delegated authority from the…

Having noted the report published in The Times of London on 20 May 2017 titled “Massive price rise for vital drug put pets’ lives at risk”, Aspen wishes to express its disappointment and concern that much of the information and clarification it provided to The Times’ Billy Kenber prior to the report being published has…